Vimarsana
Biggest News Aggregation in the World

Page 7 - Aktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aktx Today - Breaking & Trending Today

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ AKTX opened at $0.19 on Friday. The stock has a 50-day simple moving average of $0.26 and a two-hundred […]

Source: wkrb13.com
StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report report published on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 5.3 % Shares of AKTX opened at $0.20 on Friday. The stock has a market cap of $14.90 million, a […]

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright assumed coverage on Akari Therapeutics in a research report on Monday, December 5th. They set a buy rating and […]

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)

Research analysts at StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright assumed coverage on Akari Therapeutics in a report on Monday, December 5th. They set a “buy” rating and a […]

Source: wkrb13.com
StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report issued on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright started coverage on Akari Therapeutics in a research report on Monday, December 5th. They set a buy rating and a $1.50 price objective […]